Dewmar International Health & Wellness Research Consortium, LLC, a subsidiary of Dewmar, is a direct investor in New West Genetics and through New West, the consortium is using proprietary technologies and a knowledge base to genetically engineer the cannabis sativa plant to create low THC varieties that will be far superior to the common varieties known in the world today.
New West’s business strategy is using genomic technology and data-driven discovery to create large-scale, harvestable cannabis, greatly enhancing the sustainability of the industry and paving the way for large-scale product development of novel nutritional and therapeutic extracts, serving the fastest growing and largest segment of the cannabis market, to use its technology and its knowledge base of genetic engineering to develop and market what it believes are superior, differentiated products.
New West Genetics has made significant progress in 2017 including entering into a seed licensing deal with potential revenue of $3 million over 3 years. The company’s proprietary RELY™ hemp seed is the first United States hemp-bred seed to pass a Colorado Department of Agriculture trial. RELY™ was planted in five diverse regions including variations in altitude and weather pattern. The result of the trial reached a successful endpoint when the THC content never exceeded .2% (two-tenths of a percent THC). In a Colorado seed lab test, the RELY™ seed resulted in 99% purity, 99% germination and 0% weeds.
“Ultimately, my vision is to conduct research with the assistance of New West and one or more Historically Black Colleges and Universities (HBCUs) to create a high CBD, low THC producing hemp seed that contains the proper combination of healing and pain relief proteins to manufacture and distribute the first over-the-counter nutritional supplement to generate millions of dollars in revenue per month,” says Dr. Marco Moran, CEO of Dewmar International.
Dewmar is also proud to announce that New West’s seeds have been entered into trials at the University of Kentucky and Purdue, two of the leading agricultural colleges in the United States. Both universities are active participants in the nationwide revival of the hemp industry.
New West has 4 breeding sites this year plus a 20-acre site which is currently producing hemp from the genetically engineered seed RELY™. This large production will give the company verifiable yield rates, which will be demonstrable to large buyers who are looking for seeds in the United States.
One of the key researchers behind New West’s work is Dr. John McKay. Dr. McKay is the Chief Investigator at the McKay Lab at Colorado State. The McKay Lab studies the ecology, evolution and genetics of local plant adaptation in natural plant populations. Dr. McKay was invited as a special guest by Dr. Moran to meet his long-time friend and colleague, Dr. Toldson, at a national White House Initiative on HBCU conference years ago. By the end of the conference, Dr. McKay renewed and strengthened his commitment to advance the post-graduate education and increased participation of HBCU students in the studies of Plant Genetics.